CSF1 and giant cell tumor of soft tissue: Considering these findings, however, we speculate that CSF1R inhibitors such as pexidartinib might be a possible therapeutic option for advanced/metastatic GCTST, if the CSF1/CSF1R pathway is involved in the pathogenesis of GCTST.